Pharmacokinetics of SCH 56592, a New Azole Broad-Spectrum Antifungal Agent, in Mice, Rats, Rabbits, Dogs, and Cynomolgus Monkeys

Documenti analoghi

• Pharmacokinetics of an Everninomicin (SCH 27899) in Mice, Rats, Rabbits, and Cynomolgus Monkeys following Intravenous Administration
  di: Lin, C., et al.
  Pubblicazione: (2000)
• Comparative pharmacokinetics of Sch 28191 and amphotericin B in mice, rats, dogs, and cynomolgus monkeys.
  di: Kim, H, et al.
  Pubblicazione: (1984)
• In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against Aspergillus and Candida
  di: Cacciapuoti, Anthony, et al.
  Pubblicazione: (2000)
• Treatment of Murine Fusariosis with SCH 56592
  di: Lozano-Chiu, M., et al.
  Pubblicazione: (1999)
• In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
  di: Perfect, J R, et al.
  Pubblicazione: (1996)